| Nome |
# |
|
Metabolomic approach to profile functional and metabolic changes in heart failure, file e2f56ed4-7125-3eaf-e053-3a05fe0a5d97
|
712
|
|
Women-specific predictors of cardiovascular disease risk - new paradigms, file e2f56ed7-f9a7-3eaf-e053-3a05fe0a5d97
|
577
|
|
La Metabolomica: una nuova era in Cardiologia.
Le nostre esperienze originali nei campi dell' insufficienza cardiaca, della cardiopatia ischemica e dell' ipertensione polmonare, file e2f56ed8-4655-3eaf-e053-3a05fe0a5d97
|
566
|
|
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients, file e2f56ed4-cf88-3eaf-e053-3a05fe0a5d97
|
282
|
|
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography, file e2f56ed8-3bde-3eaf-e053-3a05fe0a5d97
|
246
|
|
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance, file e2f56ed5-75e7-3eaf-e053-3a05fe0a5d97
|
239
|
|
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance, file e2f56ed5-8737-3eaf-e053-3a05fe0a5d97
|
128
|
|
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state, file e2f56ed8-30a2-3eaf-e053-3a05fe0a5d97
|
124
|
|
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases, file e2f56ed8-3be0-3eaf-e053-3a05fe0a5d97
|
121
|
|
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine, file e2f56ed6-e141-3eaf-e053-3a05fe0a5d97
|
118
|
|
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation, file e2f56ed3-ae6e-3eaf-e053-3a05fe0a5d97
|
112
|
|
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease, file e2f56ed6-94f5-3eaf-e053-3a05fe0a5d97
|
110
|
|
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors, file e2f56ed9-1277-3eaf-e053-3a05fe0a5d97
|
110
|
|
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study., file e2f56ed3-c919-3eaf-e053-3a05fe0a5d97
|
108
|
|
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects, file e2f56ed6-04a4-3eaf-e053-3a05fe0a5d97
|
86
|
|
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway, file e2f56ed9-0d40-3eaf-e053-3a05fe0a5d97
|
66
|
|
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection, file e2f56ed8-fca5-3eaf-e053-3a05fe0a5d97
|
44
|
|
Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review, file 61659c2b-9169-431b-aec2-4e2336a794f5
|
30
|
|
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection, file 1eff2179-8902-456d-89cc-171cf4cc178c
|
18
|
|
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry, file e2f56ed9-446f-3eaf-e053-3a05fe0a5d97
|
12
|
|
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology, file e2f56ed3-9ebf-3eaf-e053-3a05fe0a5d97
|
8
|
|
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry, file e2f56ed4-cf86-3eaf-e053-3a05fe0a5d97
|
8
|
|
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry, file e2f56ed8-3bd2-3eaf-e053-3a05fe0a5d97
|
8
|
|
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue?, file e2f56ed8-1a97-3eaf-e053-3a05fe0a5d97
|
7
|
|
Association of endodontic infection with detection of an initial lesion to the cardiovascular system, file e2f56ed3-c866-3eaf-e053-3a05fe0a5d97
|
6
|
|
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension, file e2f56ed6-7aa0-3eaf-e053-3a05fe0a5d97
|
6
|
|
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography, file e2f56ed8-8f8a-3eaf-e053-3a05fe0a5d97
|
6
|
|
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy, file e2f56eda-80d4-3eaf-e053-3a05fe0a5d97
|
6
|
|
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women, file e2f56ed5-ca5a-3eaf-e053-3a05fe0a5d97
|
5
|
|
Metabolomics: a new era in cardiology?, file e2f56ed3-c86c-3eaf-e053-3a05fe0a5d97
|
4
|
|
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X, file e2f56ed4-d3ee-3eaf-e053-3a05fe0a5d97
|
4
|
|
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells, file e2f56ed5-d8f2-3eaf-e053-3a05fe0a5d97
|
4
|
|
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype, file e2f56ed6-02b5-3eaf-e053-3a05fe0a5d97
|
4
|
|
Coronary Artery Disease, file e2f56eda-43e5-3eaf-e053-3a05fe0a5d97
|
4
|
|
Cardiovascular Risk Perception and Knowledge among Italian Women: Lessons from IGENDA Protocol, file 88ada491-e245-4eba-a80c-4831ec1c98b7
|
3
|
|
null, file e2f56ed3-a732-3eaf-e053-3a05fe0a5d97
|
3
|
|
null, file e2f56ed3-b9e8-3eaf-e053-3a05fe0a5d97
|
3
|
|
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women, file e2f56ed7-5ce7-3eaf-e053-3a05fe0a5d97
|
3
|
|
Vascular damage-Coronary artery disease, file e2f56ed9-26f0-3eaf-e053-3a05fe0a5d97
|
3
|
|
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC), file e2f56ed9-6216-3eaf-e053-3a05fe0a5d97
|
3
|
|
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world, file e2f56ed9-89e1-3eaf-e053-3a05fe0a5d97
|
3
|
|
null, file e2f56ed3-c8c0-3eaf-e053-3a05fe0a5d97
|
2
|
|
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers, file e2f56ed3-d722-3eaf-e053-3a05fe0a5d97
|
2
|
|
Relationship between high values of HOMA-IR and cardiovascular response to metformin, file e2f56ed4-94d6-3eaf-e053-3a05fe0a5d97
|
2
|
|
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment, file e2f56ed6-0354-3eaf-e053-3a05fe0a5d97
|
2
|
|
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention, file e2f56ed7-abe1-3eaf-e053-3a05fe0a5d97
|
2
|
|
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry, file e2f56ed9-0d45-3eaf-e053-3a05fe0a5d97
|
2
|
|
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype, file e2f56ed9-257b-3eaf-e053-3a05fe0a5d97
|
2
|
|
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity, file e2f56ed9-446a-3eaf-e053-3a05fe0a5d97
|
2
|
|
Gender-specific aspects in primary and secondary prevention of cardiovascular disease, file e2f56ed3-a497-3eaf-e053-3a05fe0a5d97
|
1
|
|
Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease, file e2f56ed3-a5b2-3eaf-e053-3a05fe0a5d97
|
1
|
|
Gender determinants of cardiovascular risk factors and diseases, file e2f56ed3-b06a-3eaf-e053-3a05fe0a5d97
|
1
|
|
Cardiac effects of L-thyroxine administration in borderline hypothyroidism, file e2f56ed3-ba19-3eaf-e053-3a05fe0a5d97
|
1
|
|
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction?, file e2f56ed4-68c8-3eaf-e053-3a05fe0a5d97
|
1
|
|
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection, file e2f56ed5-ec22-3eaf-e053-3a05fe0a5d97
|
1
|
|
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy, file e2f56ed5-f6f6-3eaf-e053-3a05fe0a5d97
|
1
|
|
Metabolomics, a promising approach to translational research in cardiology, file e2f56ed5-f9d3-3eaf-e053-3a05fe0a5d97
|
1
|
|
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus, file e2f56ed6-03fe-3eaf-e053-3a05fe0a5d97
|
1
|
|
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection, file e2f56ed7-29a0-3eaf-e053-3a05fe0a5d97
|
1
|
|
Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients, file e2f56ed7-606a-3eaf-e053-3a05fe0a5d97
|
1
|
|
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu", file e2f56ed7-69be-3eaf-e053-3a05fe0a5d97
|
1
|
|
The need of a gender-corrected evidence based medicine, file e2f56ed7-8d1e-3eaf-e053-3a05fe0a5d97
|
1
|
|
Looking for the gender equality, file e2f56ed7-b59e-3eaf-e053-3a05fe0a5d97
|
1
|
|
Gender differences in cardiology: is it time for new guidelines?, file e2f56ed7-f94c-3eaf-e053-3a05fe0a5d97
|
1
|
|
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study, file e2f56ed7-f99e-3eaf-e053-3a05fe0a5d97
|
1
|
|
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs, file e2f56ed8-1aa9-3eaf-e053-3a05fe0a5d97
|
1
|
|
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects, file e2f56ed8-3bd0-3eaf-e053-3a05fe0a5d97
|
1
|
|
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry, file e2f56ed8-7b25-3eaf-e053-3a05fe0a5d97
|
1
|
|
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer, file e2f56ed9-0517-3eaf-e053-3a05fe0a5d97
|
1
|
|
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study, file e2f56eda-3ab6-3eaf-e053-3a05fe0a5d97
|
1
|
| Totale |
3.947 |